4//SEC Filing
LEXICON PHARMACEUTICALS, INC. 4
Accession 0001127602-15-005041
$LXRXCIK 0001062822operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:44 PM ET
Size
7.7 KB
Accession
0001127602-15-005041
Insider Transaction Report
Form 4
NORTHCOTT JOHN
VP, Marketing, Comm Strategy
Transactions
- Award
Stock Option (Right to Buy)
2015-02-05+482,400→ 482,400 totalExercise: $0.89Exp: 2025-02-05→ Common Stock (482,400 underlying) - Award
Restricted Stock Units (Phantom Stock)
2015-02-05+120,600→ 120,600 total→ Common Stock (120,600 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/5/16) and vests 1/48th per month for each month of service thereafter.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001062822
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:44 PM ET
- Size
- 7.7 KB